Search clinical trials for: RDN

Total 178 results

CSL Behring

Completed

An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A

Hemophilia A

United States, Australia, Austria, Canada, Czech Republic, Germany, Hungary, Italy, Japan, Lebanon, Malaysia, Netherlands, Philippines, Poland, Romania, Russian Federation, South Africa, Spain, Ukraine, United Kingdom
King Faisal Specialist Hospital & Research Center

Completed

Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN) (GLUCOSE-in-PN)

Diabetic Patients With Gastrointestinal Cancer Undergoing Surgery and Receiving Parenteral Nutrition

Saudi Arabia
Meshalkin Research Institute of Pathology of Circulation

Unknown

Comparison of Redo PVI With vs. Without Renal Denervation for Recurrent AF After Initial PVI

Atrial Fibrillation | Arterial Hypertension

Russian Federation, United States
Lepu Medical Technology (Beijing) Co., Ltd.
Chinese Academy of Medical Sciences, Fuwai Hospital

Completed

LEPU Renal Denervation System for Resistant Hypertension (LEPU-RDN)

Cardiovascular Diseases | Vascular Diseases | Hypertension
UMC Utrecht
Dutch Kidney Foundation

Unknown

The Dutch National Renal Denervation Registry (NL_RDN_REG)

Hypertension

Netherlands
Medtronic Vascular

Completed

Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2) (HTN-2)

Uncontrolled Hypertension

Spain, Australia, Germany, France, Latvia, United Kingdom, Belgium, Austria, Poland, Switzerland
Seoul St. Mary's Hospital
Daiichi Sankyo Korea Co., Ltd.; Daewoong Pharmaceutical Co. LTD.

Unknown

Effect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension

Hypertension

Korea, Republic of
Sahlgrenska University Hospital, Sweden

Unknown

PCI and Renal Denervation in Hypertensive Patients With Acute Coronary Syndromes (COMBI-RDN)

Hypertension | Acute Myocardial Infarction

Sweden
Mannkind Corporation

Completed

Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up

Diabetes Type 2

Brazil, Spain, United States, Argentina, Canada, Chile, Mexico, Poland, Russian Federation, United Kingdom
Grace Hospital, Cleveland, Ohio
Abbott Nutrition

Unknown

Efficacy of Oxepa Enteral Feeding in LTAC (Long Term Acute Care Hospital) Patients on Chronic Ventilation- a Pilot Study (ANUS1305)

Acute Lung Injury | Mechanical Ventilation Complication | Dietary Modification

United States
University of Adelaide

Unknown

Effects of Renal Sympathetic Denervation on the Cardiac and Renal Functions in Patients With Drug-resistant Hypertension Through MRI Evaluation (RDN)

Uncontrolled Hypertension

Australia
Eli Lilly and Company

Completed

A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults (HypoCCS)

Hypopituitarism | Pituitary Insufficiency | Growth Hormone Deficiency, Adult
University of Guadalajara
Instituto Mexicano del Seguro Social

Completed

Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy

Diabetes Mellitus Type 2 | Non-proliferative Diabetic Retinopathy

Mexico
Bio Sidus SA

Unknown

Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo

Postmenopausal Osteoporosis With Pathological Fracture

Argentina
Charles University, Czech Republic
Mount Sinai Hospital, New York; General University Hospital, Prague; Na Homolce...

Unknown

Renal Protection Using Sympathetic Denervation in Patients With Chronic Kidney Disease (KPS)

Arterial Hypertension | Chronic Renal Insufficiency

Czech Republic
University of Witten/Herdecke

Unknown

Impact of Catecholamine Spill-over on Outcome After RDN and EP Ablation (RDN-Cath-1)

Hypertension

Germany
Medtronic Diabetes

Completed

Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration (MIP310)

Type 1 Diabetes

United States
Massachusetts General Hospital

Unknown

Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight

Fetal Growth Retardation

United States
Sanofi

Completed

Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment

Diabetes Mellitus

United States
Sanofi

Completed

Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents

Diabetes Mellitus

United States
Sanofi

Completed

Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin

Diabetes Mellitus, Type 2

United States
Eli Lilly and Company

Completed

Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome

Failure to Thrive

United States
Eli Lilly and Company

Completed

Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes

Type 2 Diabetes

United States
Pfizer

Completed

Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety (VOLUME)

Diabetes Mellitus

United States, Germany, Sweden, United Kingdom, Puerto Rico
Massachusetts General Hospital

Terminated

Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature

Turner Syndrome | Idiopathic Short Stature

United States
BioPartners GmbH
LG Life Sciences

Completed

Sustained Release Formulation of Somatropin (rDNA Origin)for Injection

Growth Hormone Deficiency
Eli Lilly and Company

Completed

Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin

Type 2 Diabetes Mellitus

United States, Spain, United Kingdom
Eli Lilly and Company

Completed

Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopathic Short Stature

Growth Disorder

United States

Search clinical trials for: RDN

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations